Compare Heron Therapeutics Inc (HRTX) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Summit Therapeutics Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Summit Therapeutics Inc trades at $14.58 (market cap $10.48B). The key difference: Summit Therapeutics Inc is far larger — about 114.6× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | SMMT | |
|---|---|---|
Market Cap | $91.46M | $10.48B |
Sector | Health | Health |
52-Week High | $1.96 | $29.32 |
52-Week Low | $0.39 | $13.05 |
Enterprise Value | $189.36M | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
